Skip to main content
. 2022 Aug 18;14(8):1731. doi: 10.3390/pharmaceutics14081731

Figure 8.

Figure 8

The impact of GB-PPNPs on striatal. The levels of (A) MDA, (B) SOD, (C) GSH-Px (means ± SD, n = 4), (D) dopamine, (E) DOPAC, and (F) HVA (n = 7). * p < 0.05 and ** p < 0.01 corresponds to different treatments vs. MPTP. # p < 0.05 and ## p < 0.01 corresponds to GB-PPNPs vs. GB.